Who owns BIOXCEL THERAPEUTICS INC COM NEW?
- Ticker: BTAI
- CUSIP Number: 09075p204
Tip: Access positions for across all investors
Analyze quarterly positions in Bioxcel Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioxcel Therapeutics stock
Who bought or sold BIOXCEL THERAPEUTICS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 1.0M | $2.6M | 100% | Sep 2025 |
|
| Oaktree Capital Management | 241k | $617k | 0% | Sep 2025 |
|
| FMR | 199k | $508k | 100% | Sep 2025 |
|
| Vanguard Group | 192k | $492k | 921% | Sep 2025 |
|
| Geode Capital Management | 125k | $321k | 344% | Sep 2025 |
|
| XTX Topco | 113k | $290k | 384% | Sep 2025 |
|
| BlackRock | 84k | $216k | 374% | Sep 2025 |
|
| State Street Corporation | 53k | $135k | 100% | Sep 2025 |
|
| UBS Group | 44k | $112k | 9% | Sep 2025 |
|
| Oaktree Fund Advisors | 43k | $110k | 0% | Sep 2025 |
|
| Northern Trust | 38k | $97k | 100% | Sep 2025 |
|
| Jones Financial Companies, L.L | 36k | $97k | 38% | Sep 2025 |
|
| HighTower Advisors | 35k | $90k | 42% | Sep 2025 |
|
| Foundations Investment Advisors | 30k | $76k | 100% | Sep 2025 |
|
| SLT Holdings | 30k | $76k | 100% | Sep 2025 |
|
| Wells Fargo & Company | 16k | $42k | -4% | Sep 2025 |
|
| Advisor Group Holdings | 15k | $39k | 198% | Sep 2025 |
|
| Diversify Wealth Management | 15k | $29k | 0% | Sep 2025 |
|
| IFP Advisors | 4.4k | $11k | 100% | Sep 2025 |
|
| Tower Research Capital | 3.9k | $10k | 187% | Sep 2025 |
|
| Group One Trading | 2.2k | $5.8k | 77% | Sep 2025 |
|
| Morgan Stanley | 1.6k | $2.9k | 100% | Jun 2025 |
|
| Goss Wealth Management | 1.3k | $3.4k | 4194% | Sep 2025 |
|
| AllSquare Wealth Management | 175.00 | $316.995000 | 0% | Jun 2025 |
|
| SBI Securities | 169.00 | $432.994900 | -81% | Sep 2025 |
|
| Washington Trust Advisors | 160.00 | $410.000000 | 0% | Sep 2025 |
|
| Parkside Financial Bank & Trust | 112.00 | $287.000000 | 0% | Sep 2025 |
|
| Zurcher Kantonalbank | 103.00 | $263.999300 | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 60.00 | $154.002000 | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 45.00 | $115.002000 | -61% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 39.00 | $99.999900 | -11% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 21.00 | $53.999400 | 0% | Sep 2025 |
|
| Triumph Capital Management | 1.00 | $3.000000 | 100% | Sep 2025 |
|
| Us Bancorp | 1.00 | $3.000000 | 0% | Sep 2025 |
|
Who sold out of Bioxcel Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Murchinson | Jun 2025 | 81k | $146k |
| Goldman Sachs Group | Mar 2025 | 25k | $50k |
| Beacon Pointe Advisors | Jun 2025 | 19k | $34k |
| Citadel Advisors | Jun 2025 | 11k | $21k |
| Raymond James Financial | Jun 2025 | 125.00 | $226.000000 |
| Barclays | Jun 2025 | 8.00 | $0 |
| National Bank Of Canada /fi/ | Jun 2025 | 6.00 | $10.999800 |
| Federation des caisses Desjardins du Quebec | Jun 2025 | 1.00 | $2.000000 |
| Mount Yale Investment Advisors | Jun 2025 | 1.00 | $2.000000 |